Poor overall performance of the resmetirom NIT algorithm: a multinational comparison across four tertiary care centers in Germany, Türkiye, and the United States

Background and objective: Resmetirom was recently approved in Europe as the first pharmacologic therapy for patients with metabolic dysfunction–associated steatohepatitis (MASH) and fibrosis stages F2–F3. Recently, a combination of NITs has been proposed to identify treatment-eligible [for full text, please go to the a.m. URL]

Authors

Institutions

Publication Details

Journal
German Medical Science (German Research Foundation)
Published
2026-06-18
DOI
https://doi.org/10.3205/26vzmnrw106
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Poor overall performance of the resmetirom NIT algorithm: a multinational comparison across four tertiary care centers in Germany, Türkiye, and the United States

N. Alkhouri, R. Vuppalanchi, S. Kahlon, Y. Yilmaz et al.
German Medical Science (German Research Foundation)
Liver Disease Diagnosis and Treatment
article

Poor overall performance of the resmetirom NIT algorithm: a multinational comparison across four tertiary care centers in Germany, Türkiye, and the United States

N. Alkhouri, R. Vuppalanchi, S. Kahlon, Y. Yilmaz, E Kaya, A. Canbay, R. Nadeem, A. Jain, S. Hemant, R. Shah, C. Nyguyen, J. P. Sowa, M. Chughtai
article en

Abstract

Background and objective: Resmetirom was recently approved in Europe as the first pharmacologic therapy for patients with metabolic dysfunction–associated steatohepatitis (MASH) and fibrosis stages F2–F3. Recently, a combination of NITs has been proposed to identify treatment-eligible [for full text, please go to the a.m. URL]

German Medical Science (German Research Foundation)
Recep Tayyip Erdoğan University (TR), Universitätsklinikum Knappschaftskrankenhaus Bochum (DE), Summit School (US), Arizona Liver Health (US), Indiana University – Purdue University Indianapolis (US)
No poverty
Openalex Percentile: Top 6%
Liver Disease Diagnosis and Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.